Biotech news, latest stories & analysis

Find today's trending Biotech news & headlines

Interview: Psychedelics changing the course of depression; stocks trading on volatility not fundamentals, says Cybin CEO Doug Drysdale
Interview: Psychedelics changing the course of depression; stocks trading on volatility not fundamentals, says Cybin CEO Doug Drysdale
  • Psychedelics-based meds changing the course of depression, unlike antidepressants that only treat symptoms.
  • RFK Jr's openness to psychedelic treatment within a regulatory framework a good thing.
  • Inevitable that Big Pharma gets involved in psychedelics at some point. It's too big an opportunity to miss.
April 9, 2025
Biotech stocks plunge as FDA’s Peter Marks resigns over RFK Jr. dispute, Moderna and Beam Therapeutics hit hard
Biotech stocks plunge as FDA’s Peter Marks resigns over RFK Jr. dispute, Moderna and Beam Therapeutics hit hard
March 31, 2025
23andMe files for bankruptcy: what went wrong?
23andMe files for bankruptcy: what went wrong?
March 24, 2025

Trending news

Trading ideas & analysis

Cassava Sciences stock forecast: is it safe to buy the SAVA dip?
July 1, 2024
My Novavax stock price forecast was correct: what next now?
June 6, 2024
Ocugen stock price analysis: good progress but a risky pattern forms
May 29, 2024
Here are the top Russell 2000 (IWM) ETF stocks of 2024
May 7, 2024
Ocugen stock is a good speculative buy but there’s 1 key risk
Iovance (IOVA) stock price could jump by 30% after earnings
Here’s why Cathie Wood’s Ginkgo Bioworks (DNA) stock has dived
Janux Therapeutics (JANX) stock has gone parabolic: what next?
Here’s why ImmunityBio (IBRX) stock price surged and what next
Best biotech stocks to buy and hold in 2024: VKTX, SANA, RXRX

More breaking stories

Privia Health, Corcept and three other low-key but high-earnings growth potential stocks to invest in 2025
Privia Health, Corcept and three other low-key but high-earnings growth potential stocks to invest in 2025 March 4, 2025
Cathie Wood names AI’s most overlooked game-changing application
Cathie Wood names AI’s most overlooked game-changing application February 4, 2025
Why did Akero (AKRO) stock soar 110% on Monday?
Why did Akero (AKRO) stock soar 110% on Monday? January 27, 2025
Moderna stock takes a 20% hit: here’s why
Moderna stock takes a 20% hit: here’s why January 13, 2025
Why are Zomato, Biocon and ONGC shares buzzing today?
Why are Zomato, Biocon and ONGC shares buzzing today? January 7, 2025
Traws Pharma stock soars 200% on encouraging bird flu drug data
Traws Pharma stock soars 200% on encouraging bird flu drug data December 23, 2024
Humacyte stock may fail to sustain today’s gains: find out more
Humacyte stock may fail to sustain today’s gains: find out more December 20, 2024
Top 3 global stocks poised for 40% gains by 2025
Top 3 global stocks poised for 40% gains by 2025 December 3, 2024
Cassava Sciences plummets 85% after Alzheimer’s drug trial failure
Cassava Sciences plummets 85% after Alzheimer’s drug trial failure November 25, 2024
This biotech stock soared a whopping 900% on Wednesday: here’s why
This biotech stock soared a whopping 900% on Wednesday: here’s why October 16, 2024
AbbVie stock analysis: Rinvoq and Skyrizi are big catalysts
AbbVie stock analysis: Rinvoq and Skyrizi are big catalysts October 1, 2024
Vanda Pharmaceuticals decries FDA’s rejection of stomach paralysis drug as unjust
Vanda Pharmaceuticals decries FDA’s rejection of stomach paralysis drug as unjust September 19, 2024
Fulcrum Therapeutics stock tanks after Phase 3 trial failure of muscular dystrophy drug
Fulcrum Therapeutics stock tanks after Phase 3 trial failure of muscular dystrophy drug September 12, 2024
Vaxcyte stock soars 35% on promising VAX-31 vaccine trial results
Vaxcyte stock soars 35% on promising VAX-31 vaccine trial results September 3, 2024
Virax Biolabs stock soars 45% on Mpox detection kit deal: What you need to know
Virax Biolabs stock soars 45% on Mpox detection kit deal: What you need to know August 28, 2024
Why Addex Therapeutics stock skyrocketed 70% on Tuesday
Why Addex Therapeutics stock skyrocketed 70% on Tuesday August 27, 2024
Forget Eli Lilly: Why Johnson & Johnson could be the next trillion-dollar pharma stock
Forget Eli Lilly: Why Johnson & Johnson could be the next trillion-dollar pharma stock August 22, 2024
Cingulate stock surges 115% after European patent approval for ADHD treatment: Is it a buy?
Cingulate stock surges 115% after European patent approval for ADHD treatment: Is it a buy? August 16, 2024
BofA downgrades Silicon Motion, slashes price target to $60: Time to sell or hold?
BofA downgrades Silicon Motion, slashes price target to $60: Time to sell or hold? August 16, 2024
Elon Musk’s Neuralink advances with second human implant: 400 electrodes active as trials progress
Elon Musk’s Neuralink advances with second human implant: 400 electrodes active as trials progress August 5, 2024
RBC downgrades Moderna and cuts price target by 28%: Should you exit?
RBC downgrades Moderna and cuts price target by 28%: Should you exit? August 5, 2024
Eli Lilly’s tirzepatide injection results could trigger another bull run: Here’s why
Eli Lilly’s tirzepatide injection results could trigger another bull run: Here’s why August 1, 2024
1 3 … 12

Other topics

5G news
AI news
Agriculture stocks news
Airline news
Cannabis news
Construction news
Dividend news
ETFs news
Earnings Reports news
Education news
Electric Vehicle (EV) news